New Key Statistics Module, Z-Score and F-Score
TSX:AVCN Key Ratios
Market Cap C$ M | 29.93 |
Enterprise Value C$ M | 31.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 18.50 |
Price/Book | -- |
Price/Sales | 1.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 24.00 |
EPS (TTM) C$ | -0.10 |
Beneish M-Score | -1.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 33.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.50 |
EV-to-EBITDA | -5.19 |
PEG | -- |
Shares Outstanding M | 106.91 |
Net Margin (%) | -29.90 |
Operating Margin % | -27.46 |
Pre-tax Margin (%) | -29.86 |
Quick Ratio | 0.33 |
Current Ratio | 0.69 |
ROA % (ttm) | -33.90 |
ROE % (ttm) | -2,067.26 |
ROIC % (ttm) | -43.80 |
Dividend Yield % | -- |
Altman Z-Score | -5.76 |
TSX:AVCN Number of Guru Trades
TSX:AVCN Volume of Guru Trades
Gurus Latest Trades with TSX:AVCN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:AVCN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Avicanna Inc Insider Transactions
No Available Data